Transcriptional regulation by TAL1: A link between epigenetic modifications and erythropoiesis

Epigenetics

Volumn 4, Issue 6, 2009, Pages 357-361

  Hu, Xin ^a   Ybarra, River ^b   Qiu, Yi ^b,c   Bungert, Jörg ^b   Huang, Suming ^b,c  

^a JILIN UNIVERSITY   (China)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

H3K4 demethylation; Hematopoiesis; Histone acetylation; LSD1; TAL1; Transcription

Indexed keywords

EID: 73449084804     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.4.6.9711     Document Type: Review

References (55)

1. Felsenfeld G, Groudine M. Controlling the double helix. Nature 2003; 421:1-3.
2. Kornberg RD. Chromatin structure: a repeating unit of histone and DNA. Science 1974; 184:868-71.
3. Kornberg RD, Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 1999; 98:285-94.
4. Strahl B, Allis CD. The language of covalent histone modification. Nature 2000; 403:41-5.
5. Bhaumik SR, Smith E, Shilatifard A. Covalent modifications of histones during development and disease pethogenesis. Nat Struct Mol Biol 2007; 14:1008-16.
6. Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 2007; 25:1-14.
7. Orford K, Kharchenko P, Lai W, Dao MC, Worhunsky DJ, Ferro A, et al. Differential H3K4 methylation identifies developmentally poised hematopoietic genes. Dev Cell 2008; 14:798-809.
8. Cui K, Zang C, Roh T-Y, Schones DE, Childs RW, Peng W, Zhao K. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell stem Cell 2009; 4:80-93.
9. Rice KL, Hormaeche I, Licht JD. Epigenetic regulation of normal and malignant hematopoiesis. Oncogene 2007; 26:6697-714.
10. Linggi BE, Brandt SJ, Sun Z-W, Hiebert SW. Translating the histone code into leukemia. J Cell Biochem 2005; 96:938-50.
11. Huang S, Qiu Y, Stein R, Brandt SJ. p300 functions as a transcriptional coactivator for the Tal1/SCL oncoprotein. Oncogene 1999; 18:4958-67.
12. Huang S, Brandt SJ. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol Cell Biol 2000; 20:2248-59.
13. Huang S, Qiu Y, Xu Z, Shi Y, Brandt SJ. P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL. EMBO J 2000; 19:6792-803.
14. Chen X, Bieker JJ. Unanticipated repression function linked to erythroid Krüppel-like factor. Mol Cell Biol 2001; 21:3118-25.
15. Rodriquez P, Bonte E, Krijgsveld J, Kolodziej KE, Guyot B, Heck AJ, et al. GATA-1 forms distinct activating and repressive complexes in erythroid cells. EMBO J 2005; 24:2354-66.
16. Zhang W, Kadam S, Emerson BM, Bieker JJ. Site-specific acetylation by p300 or CREB binding protein regulates erythroid Kruppel-like factor transcriptional activity via its interaction with SWI-SNF complex. Mol Cell Biol 2001; 21:2413-22.
17. Blobel GA, Nakajima T, Eckner R, Montminy M, Orkin SH. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc Natl Acad Sci USA 1998; 95:2061-6.
18. Hung HL, Lau J, Kin AY, Weiss MJ, Blobel GA. CREB-binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites. Mol Cell Biol 1999; 19:3496-505.
19. Hong W, Nakazawa M, Chen YY, Kori R, Vakoc CR, Rakowski C, et al. FOG-1 regruite the NURD repressor complex to mediate transcriptional repression by GATA-1. EMBO J 2005; 24:67-78.
20. Hung HL, Kim AY, Hong W, Rakowski C, Blobel GA. Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation. J Biol Chem 2001; 276:10715-21.
21. Rosenbauer F, Tenen DG. Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol 2007; 7:105-17.
22. Aplan PD, Lombardi DP, Ginsberg AM, Cossman J, Bertness VL, Kirsch IR. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science 1990; 250:1426-9.
23. Chen Q, Cheng J-T, Tsai L-H, Schneider N, Buchanan G, Carroll A, et al. The tal1 gene undergo chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J 1990; 9:415-24.
24. Finger LR, Kagan J, Christopher G, Kurtzberg J, Hershfield MS, Nowell PC, Croce CM. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA 1989; 86:5039-43.
25. Porcher C, et al. The T cell leukemia oncoprotein SCL/tal1 is essential for development of all hematopoietic lineages. Cell 1996; 86:47-57.
26. Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature 1995; 373:432-4.
27. Robb L, Lyons I, Li R, Hartley L, Köntgen F, Harvey RP, et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of scl gene. Proc Natl Acad Sci USA 1995; 92:7075-9.
28. Robb L, Elwood NJ, Elefanty AG, Köntgen F, Li R, Barnett LD, Begley CG. The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J 1996; 15:4123-9.
29. Wadman IA, Hirotaka O, Grutz CG, Agulnick AD, Westphal H, Forster A, Rabbitts TH. The LIM-only protein Lmo2 is abridging molecule assembling an erythroid DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NL1 protein. EMBO J 1997; 16:3145-57.
30. Anderson KP, Crable SC, Lingrel JB. The GATA-E-box motif in the EKLF promoter is required for in vivo expression. Blood 2000; 95:1652-5.
31. Xu Z, Huang S, Chang L-S, Brandt SJ. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation. Mol Cell Biol 2003; 23:7585-99.
32. Vyas p, McDevitt MA, Cantor AB, Katz SG, Fujiwara Y, Orkin SH. Different sequence requirement for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development 1999; 126:2799-811.
33. Xu Z, Meng X, Cai Y, Liang H, Nagarajan L, Brandt SJ. Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteins. Genes & Dev 2007; 21:942-55.
34. Song S-H, Hou C, Dean A. A positive role for NL1/Ldb1 in long-range β-globin locus control region function. Mol Cell 2007; 28:810-22.
35. Xu Z, Meng X, Cai Y, Koury MJ, Brandt SJ. Recruitment of the SWI/SNF protein Brg1 by a multiprotein complex effects transcriptional repression in murine erythroid progenitors. Biochem J 2006; 399:297-304.
36. Schuh AH, Tipping AJ, Clark AJ, Hamlett I, Guyot B, Iborra FJ, et al. ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor function in erythropoiesis. Mol Cell Biol 2005; 25:10235-50.
37. Goardon N, Lambert JA, Rodriguez P, Nissaire P, Herblot S, Thibault P, et al. ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J 2006.
38. Davis JN, Williams BJ, Herron JT, Galiano FJ, Meyers S. ETO-2, a new member of the ETO-family of nuclear proteins. Oncogene 2003; 18:1375-83.
39. Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, et al. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol 2001; 21:6370-483.
40. Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol 1998; 18:7185-91.
41. Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci USA 1998; 95:10860-5.
42. O'Neil J, Shank J, Cusson N, Murre C, Kelliher M. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. Cancer Cell 2004; 5:587-96.
43. Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat rev Mol Cell Biol 2005; 6:838-49.
44. Sims RJ, III, Reinberg D. Hisone H3 Lys 4 methylation: caught in a bird? Genes & Dev 2006; 20:2779-86.
45. Wen J, Huang S, Pack SD, Yu X, Brandt SJ, Noguchi CT. Tal1/SCL binding to pericentromeric DNA represses transcription. J Biol Chem 2005; 280:12956-66.
46. Hu X, Li X, Valverde K, Fu X, Noguchi C, Qiu Y, Huang S. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc Natl Acad Sci USA 2009; 106:10141-6.
47. Saleque S, Kim J, Rooke HM, Orkin SH. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell 2007; 27:562-72.
48. Attema JL, Papathanasiou P, Forsberg EC, Xu J, Smale ST, Weissman IL. Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis. Proc Natl Acad Sci USA 2007; 104:12371-6.
49. Palomero T, Odom DT, O'Neil J, Ferrando AA, Margolin A, Neuberg DS, et al. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia. Blood 2006; 108:986-92.
50. Izraeli S. Leukemia - a development perspective. British J Haematology 2004; 126:3-10.
51. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119:941-53.
52. Shi Y, Matson C, Lan F, Iwase S, Baba T, Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 2005; 19:857-64.
53. Lee MG, Wynder C, Bochar DA, Hakimi M-A, Cooch N, Shiekhattar R. Functional interplay between histone demethylase and deacetylase enzymes. Mol Cell Biol 2006; 26:6395-402.
54. Prasad KSS, Brandt SJ. Target dependent effect of phosphorylation on the DNA binding activity of the TAL1/SCL oncoprotein. J Biol Chem 1997; 272:11457-62.
55. Armstrong JA, Bieker JJ, Emerson BM. A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro. Cell 1998; 95:93-104.